Pirfenidone (Esbriet) has finally been added to the PBS for patients with idiopathic pulmonary fibrosis (IPF). The PBS subsidy will come as a relief for patients who have been waiting for a number of years for improved access to the drug. The Pharmaceutical Benefits Advisory Committee (PBAC) has previously recognised ‘the high clinical need for ...
IPF drug pirfenidone now listed on PBS
6 Jul 2017